Cyanotech Profit Margin

The latest profit margin for CYAN is -4.83% as of March 2026. That compares with -13.23% in the prior-year period — up 63.5% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Cyanotech's historical trend and sector peers before judging valuation or financial health.

Over the past year, CYAN's profit margin moved from -13.23% to -4.83% — a 63.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cyanotech's valuation or profitability profile.

Against Healthcare companies, CYAN currently prints -4.83% for profit margin, while the sector average sits near 14.34%. That is roughly 133.6% below the sector mean. Large gaps often invite a closer look at Cyanotech's growth, margins, and balance sheet.

Profit Margin shows how effectively Cyanotech converts resources into returns. At -4.83%, CYAN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -13.23% in the prior-year period — up 63.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CYAN's profit margin (-4.83%), review year-over-year change from -13.23%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.